-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
International war "epidemic" operation
Science and Technology Daily, Sao Paulo, April 21 (Reporter Deng Guoqing) Recently, the new crown antibody "cocktail therapy" has been authorized by the Brazilian National Health Supervision Agency and will be used for clinical treatment.
Nursa, a researcher from the Virus Research Office of the Biomedical Research Center of Sao Paulo, told a reporter from the Science and Technology Daily that because the new coronavirus mutates very quickly, only a single antibody is used, and it is easy to invalidate the antibody due to virus mutation.
Nursa pointed out that the "cocktail therapy" has shown good results in the treatment of patients with mild and moderate symptoms of the new crown, and can reduce the chance of patients' conditions getting worse.
It is reported that according to the requirements of the Brazilian National Health Supervision Agency, the therapy is limited to hospital use and is not recommended for severely ill patients with new coronary disease.
